Tryptamine Therapeutics’s (ENP) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Tryptamine Therapeutics is a Sell.
Tryptamine Therapeutics’s (ENP) 20-Day exponential moving average is 0.03, while Tryptamine Therapeutics’s (ENP) share price is AU$0.03, making it a Sell.
Tryptamine Therapeutics’s (ENP) 50-Day exponential moving average is 0.03, while Tryptamine Therapeutics’s (ENP) share price is AU$0.03, making it a Sell.
Tryptamine Therapeutics’s (ENP) 10-Day exponential moving average is 0.03, while Tryptamine Therapeutics’s (ENP) share price is AU$0.03, making it a Sell.
Tryptamine Therapeutics’s (ENP) 100-Day exponential moving average is 0.04, while Tryptamine Therapeutics’s (ENP) share price is AU$0.03, making it a Sell.
Tryptamine Therapeutics’s (ENP) stock price is AU$0.03 and Tryptamine Therapeutics’s (ENP) 50-day simple moving average is 0.04, creating a Sell signal.
Tryptamine Therapeutics’s (ENP) stock price is AU$0.03 and Tryptamine Therapeutics’s (ENP) 100-day simple moving average is 0.04, creating a Sell signal.
Tryptamine Therapeutics’s (ENP) stock price is AU$0.03 and Tryptamine Therapeutics’s (ENP) 200-day simple moving average is 0.03, creating a Sell signal.